Intraventricular haemorrhage (IVH) is a common problem in preterm infants, being a major cause of morbidity and mortality. Despite many randomised controlled trials comparing interventions to prevent IVH, the best prevention remains unclear. This study aims to review all the interventions which intended to reduce the incidence of IVH and compare them in a network meta-analysis.
METHODS:
A search on MEDLINE, EMBASE, Emcare, and CENTRAL was performed. Randomised controlled trials which evaluated neonatal interventions with a primary aim to reduce incidence of IVH in preterm infants were eligible. A surface under a cumulative ranking curve (SUCRA) was produced to indicate the intervention’s likelihood of being the most effective for preventing IVH.
RESULTS:
40 studies were eligible, enrolling over 6760 infants. Twelve intervention groups were found, including delayed cord clamping, erythropoietin, ethamsylate, fresh frozen plasma, heparin, ibuprofen, indomethacin, magnesium, nursing interventions, sedation, tranexamic acid, and vitamin E. Vitamin E and indomethacin had the highest probability of being the best interventions to prevent IVH in premature infants, but interpretation of these results is difficult due to study limitations.
CONCLUSION:
Despite the impact of IVH, we were unable to identify a clearly beneficial treatment to reduce its incidence. Interpretation of the network meta-analysis was limited due to differences within studied populations, wide range of therapies trialled, and underlying advances in neonatal care between units, and over time. Although vitamin E and indomethacin appear to be promising candidates, contemporaneous trials of these, or novel agents, enrolling the most at-risk infants is needed urgently.
VolpeJJ. Neurology of the Newborn. 5th ed: Saunders; 2008.
2.
National Child Mortality Database. The contribution of newborn health to child.
3.
WardRM, BeachyJC. Neonatal complications following preterm birth. BJOG. 2003;110(s20):8–16.
4.
ParodiA, GovaertP, HorschS, BravoMC, RamenghiLA, eur U. S. brain group. Cranial ultrasound findings in preterm germinal matrix haemorrhage, sequelae and outcome. Pediatr Res. 2020;87(Suppl 1):13–24.
5.
McCreaHJ, MentLR. The diagnosis, management, and postnatal prevention of intraventricular hemorrhage in the preterm neonate. Clin Perinatol. 2008;35(4):777–vii.
6.
HanRH, McKinnonA, CreveCoeurTS, BakshBS, MathurAM, SmyserCD, et al. Predictors of mortality for preterm infants with intraventricular hemorrhage: A population-based study. Childs Nerv Syst. 2018;34(11):2203–13.
7.
MahoneyL, LuytK, HardingD, OddD. Treatment for post-hemorrhagic ventricular dilatation: A multiple-treatment meta-analysis. Front Pediatr. 2020;8(238).
8.
BallabhP. Pathogenesis and prevention of intraventricular hemorrhage. Clin Perinatol. 2014;41(1):47–67.
9.
GilardV, TebaniA, BekriS, MarretS. Intraventricular hemorrhage in very preterm infants: A comprehensive review. J Clin Med. 2020;9(8):2447.
10.
AncelP-Y, GoffinetF, Epipage-Writing Group, KuhnP, LangerB, MatisJ, et al. Survival and morbidity of preterm children born at 22 through 34 weeks’ gestation in France in 2011: Results of the EPIPAGE-2 cohort study. JAMA Pediatrics. 2015;169(3):230–8.
11.
RichterLL, TingJ, MuracaGM, BoutinA, WenQ, LyonsJ, et al. Temporal Trends in Preterm Birth, Neonatal Mortality, and Neonatal Morbidity Following Spontaneous and Clinician-Initiated Delivery in Canada, 2009-2016. J Obstet Gynaecol Can. 2019;41(12):1742–1751.e6.
HuttonB, SalantiG, CaldwellDM, ChaimaniA, SchmidCH, CameronC, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: Checklist and explanations. Ann Intern Med. 2015;162(11):777–84.
PapileL-A, BursteinJ, BursteinR, KofflerH. Incidence and evolution of subependymal and intraventricular hemorrhage: A study of infants with birth weights less than 1,500 gm. J Pediatr. 1978;92(4):529–34.
16.
HigginsJ, ThomasJ, ChandlerJ, CumpstonM, LiT, PageM, et al. Cochrane handbook for systematic reviews of interventions version 6.1 (updated September 2020): Cochrane; 2020. Available from: www.training.cochrane.org/handbook.
17.
PapakonstantinouT, NikolakopoulouA, HigginsJPT, EggerM, SalantiG. CINeMA: Software for semiautomated assessment of the confidence in the results of network meta-analysis. Campbell Syst Rev. 2020;16(1):e1080.
18.
WhiteIR. Multivariate Random-effects Meta-analysis. Stata J. 2009;9(1):40–56.
DoyleLW, CrowtherCA, MiddletonP, MarretS, RouseD. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev. 2009(1).
21.
RabeH, ReynoldsG, Diaz-RosselloJ. Early versus delayed umbilical cord clamping in preterm infants. The Cochrane database of systematic reviews. 2004(4):CD003248.
22.
WaltlH, FödischHJ, KurzR, HohenauerL, MitterstielerG, RösslerH. Intracranial haemorrhage in low-birth-weight infantsand prophylactic administration of coagulation-factor concentrate. Lancet. 1973;1(7815):1284–6.
23.
HemmatiF, SharmaD, Namavar JahromiB, SalarianL, FarahbakhshN. Delayed cord clamping for prevention of intraventricular hemorrhage in preterm neonates: A randomized control trial. J Matern -Fetal Neonatal Med. 2020:1–7.
24.
MohammadzadehA, FarhatAS, SaeidiR, RoshandelM, VaeziA. Postnatal preventive effect of magnesium sulfate on intraventricular hemorrhage of preterm infants. Iran J Neonatol. 2020;11(1):80–5.
25.
El-NaggarW, McMillanD, HussainA, ArmsonA, WarrenA, WhyteR, et al. The effect of umbilical cord milking on cerebral blood flow in very preterm infants: a randomized controlled study. J Perinatol. 2020.
26.
DuleyL, DorlingJ, Pushpa-RajahA, OddieSJ, YoxallCW, SchoonakkerB, et al. Randomised trial of cord clamping and initial stabilisation at very preterm birth. Arch Dis Child Fetal Neonatal Ed. 2018;103(1):F6–F14.
27.
Varij KazemiM, AkbarianradZ, ZahedpashaY, MehraeinR, Haghshenas MojaveriM. Effects of delayed cord clamping on intraventricular hemorrhage in preterm infants. Iran J Pediatr. 2017;27(5):e6570.
28.
FauchereJ-C, KollerBM, TschoppA, DameC, RueggerC, BucherHU, et al. Safety of Early High-Dose Recombinant Erythropoietin for Neuroprotection in Very Preterm Infants. J Pediatr. 2015;167(1):52–3.
29.
BensonJW, DraytonMR, HaywardC, MurphyJF, OsborneJP, RennieJM, et al. Multicentre trial of ethamsylate for prevention of periventricular haemorrhage in very low birthweight infants. Lancet. 1986;2(8519):1297–300.
30.
ElbourneD. The EC randomised controlled trial of prophylactic ethamsylate for very preterm neonates: Early mortality and morbidity. Arch Dis Child. 1994;70(5 SUPPL.):F201–F5.
31.
SanghviK, MerchantR, KarnikA, KulkarniA. Role of ethamsylate in preventing periventricular-intraventricular hemorrhage in premature infants below 34 weeks of gestation. Indian Pediatr. 1999;36:653–8.
32.
MorganM, BensonJ, CookeR. Ethamsylate reduces the incidence of periventricular haemorrhage in very low birth-weight babies Lancet. 1981;318(8251):830–1.
33.
BeverleyDW, Pitts-TuckerTJ, CongdonPJ. Prevention of intraventricular haemorrhage by fresh frozen plasma. Arch Dis Child. 1985;60(8):710–3.
34.
FuliaF, CordaroS, MeoP, GittoP, GittoE, TrimarchiG, et al. Can the administration of antithrombin III decrease the risk of cerebral hemorrhage in premature infants?Biol Neonate. 2003;83(1):1–5.
35.
DaniC, BertiniG, PezzatiM, PoggiC, GuerriniP, MartanoC, et al. Prophylactic ibuprofen for the prevention of intraventricular hemorrhage among preterm infants: A multicenter, randomized study. Pediatrics. 2005;115(6):1529–35.
36.
KalaniM, ShariatM, KhalesiN, FarahaniZ, AhmadiS. A comparison of early ibuprofen and indomethacin administration to prevent intraventricular hemorrhage among preterm infants. Acta medica Iranica. 2016;54(12):788–92.
37.
Van OvermeireB, AllegaertK, CasaerA, DebaucheC, DecaluweW, JespersA, et al. Prophylactic ibuprofen in premature infants: A multicentre, randomised, double-blind, placebo-controlled trial. Lancet. 2004;364(9449):1945–9.
38.
BandstraES, MontalvoBM, GoldbergRN, PachecoI, FerrerPL, FlynnJ, et al. Prophylactic indomethacin for prevention of intraventricular hemorrhage in premature infants. Pediatrics. 1988;82(4):533–42.
39.
HaniganWC, KennedyG, RoemischF, AndersonR, CusackT, PowersW. Administration of indomethacin for the prevention of periventricular-intraventricular hemorrhage in high-risk neonates. J Pediatr. 1988;112(6):941–7.
40.
MentLR, DuncanCC, EhrenkranzRA. Randomized indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight infants. J Pediatr. 1985;107(6):937–43.
41.
MentLR, DuncanCC, EhrenkranzRA, KleinmanCS, TaylorKJ, ScottDT, et al. Randomized low-dose indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight neonates. J Pediatr. 1988;112(6):948–55.
42.
BadaHS, GreenRS, PourcyrousM, LefflerCW, KoronesSB, MagillHL, et al. Indomethacin reduces the risks of severe intraventricular hemorrhage. J Pediatr. 1989;115(4):631–7.
43.
MentLR, EhrenkranzRA, DuncanCC, ScottDT, TaylorKJW, KatzKH, et al. Low-dose indomethacin and prevention of intraventricular hemorrhage: A multicenter randomized trial. Pediatrics. 1994;93(4):543.
44.
BadaHS, KoronesSB, PerryEH, ArheartKL, PourcyrousM, RunyanJW, 3rd, et al. Frequent handling in the neonatal intensive care unit and intraventricular hemorrhage. J Pediatr. 1990;117(1 Pt 1):126–31.
45.
AlsH, LawhonG, DuffyFH, McAnultyGB, Gibes-GrossmanR, BlickmanJG. Individualized developmental care for the very low-birth-weight preterm infant: Medical and neurofunctional effects. JAMA. 1994;272(11):853–8.
46.
KochanM, LeonardiB, FirestineA, McPaddenJ, CobbD, ShahTA, et al. Elevated midline head positioning of extremely low birth weight infants: effects on cardiopulmonary function and the incidence of periventricular-intraventricular hemorrhage. J Perinatol. 2019;39(1):54–62.
BedardMP, ShankaranS, SlovisTL, PantojaA, DayalB, PolandRL. Effect of prophylactic phenobarbital on intraventricular hemorrhage in high-risk infants. Pediatrics. 1984;73(4):435–9.
49.
DonnS, RoloffD, GoldsteinG. Prevention of intraventricular haemorrhage in preterm infants by phenobarbitone: A Controlled Trial. Lancet. 1981;318(8240):215–7.
50.
RuthV, VirkolaK, PaetauR, RaivioKO. Early high-dose phenobarbital treatment for prevention of hypoxic-ischemic brain damage in very low birth weight infants. J Pediatr. 1988;112(1):81–6.
51.
WhitelawA, PlaczekM, DubowitzL, LaryS, LeveneM. Phenobarbitone for prevention of periventricular haemorrhage in very low birth-weight infants. A randomised double-blind trial. Lancet. 1983;2(8360):1168–70.
52.
MorganME, MasseyRF, CookeRW. Does phenobarbitone prevent periventricular hemorrhage in very low-birth-weight babies?: A controlled trial. Pediatrics. 1982;70(2):186–9.
53.
KubanKC, LevitonA, KrishnamoorthyKS, BrownER, TeeleRL, BaglivoJA, et al. Neonatal intracranial hemorrhage and phenobarbital. Pediatrics. 1986;77(4):443–50.
54.
AnandKJ, HallRW, DesaiN, ShephardB, BergqvistLL, YoungTE, et al. Effects of morphine analgesia in ventilated preterm neonates: primary outcomes from the NEOPAIN randomised trial. Lancet. 2004;363(9422):1673–82.
55.
HenseyOJ, MorganME, CookeRW. Tranexamic acid in the prevention of periventricular haemorrhage. Arch Dis Child. 1984;59(8):719–21.
56.
ChangGY, LuederFL, DiMicheleDM, RadkowskiMA, McWilliamsLJ, JansenRD. Heparin and the risk of intraventricular hemorrhage in premature infants. J Pediatr. 1997;131(3):362–6.
57.
BarekatainB, SaraeianS, FarghadaniM, ArmanianAM, ShahsanaeeA, RouhaniE, et al. Effect of vitamin E in prevention of intraventricular hemorrhage in preterm neonates. Int J Prev Med. 2018;9:97.
58.
ChiswickML, JohnsonM, WoodhallC, GowlandM, DaviesJ, et al. Protective effect of vitamin E (DL-alpha-tocopherol) against intraventricular haemorrhage in premature babies. Br Med J (Clin Res Ed). 1983;287:81–4.
59.
ChiswickM, GladmanG, SinhaS, TonerN, DaviesJ. Prophylaxis of periventricular hemorrhage in preterm babies by vitamin E supplementation. Ann N Y Acad Sci. 1989;570:197–7.
60.
FishWH, CohenM, FranzekD, WilliamsJM, LemonsJA. Effect of intramuscular vitamin E on mortality and intracranial hemorrhage in neonates of grams or less. Pediatrics. 1990;85(4):578–84.
61.
SpeerME, BlifeldC, RudolphAJ. Intraventricular hemorrhage and vitamin E in the very low-birth-weight infant: Evidence for efficacy of early intramuscular vitamin E administration. Pediatrics. 1984;74(6):1107–16.
62.
SinhaS, DaviesJ, TonerN, BogleS, ChiswickM. Vitamin E supplementation reduces frequency of periventricular haemorrhage in very preterm babies. Lancet. 1987;1(8531):466–71.
63.
KazemiMV, AkbarianradZ, ZahedpashaY, MehraeinR, MojaveriMH. Effects of Delayed Cord Clamping on Intraventricular Hemorrhage in Preterm Infants. Iran J Pediatr. 2017;27(5):1–4.
64.
PhelpsDL, RosenbaumAL, IsenbergSJ. Tocopherol efficacy and safety for preventing retinopathy of prematurity: A randomized, controlled, double-masked trial. Pediatrics. 1987;79(4):489–500.
65.
KubanKC, LevitonA, BrownER, KrishnamoorthyK, BaglivoJ, SullivanKF, et al. Respiratory complications in low-birth-weight infants who received phenobarbital. Am J Dis Child. 1987;141(9):996–9.
66.
ThorpJA, ParriottJ, Ferrette-SmithD, MeyerBA, CohenGR, JohnsonJ. Antepartum vitamin K and phenobarbital for preventing intraventricular hemorrhage in the premature newborn: A randomized, double-blind, placebo-controlled trial. Obstet Gynecol. 1994;83(1):70–6.
67.
BanksBA, CnaanA, MorganMA, ParerJT, MerrillJD, BallardPL, et al. Multiple courses of antenatal corticosteroids and outcome of premature neonates. North American Thyrotropin-Releasing Hormone Study GrouAm J Obstet Gynecol. 1999;181(3):709–17.
68.
MohamedMA, AlyH. Transport of premature infants is associated with increased risk for intraventricular haemorrhage. Arch Dis Child Fetal Neonatal Ed. 2010;95(6):F403.
69.
de Bijl-MarcusK, BrouwerAJ, De VriesLS, GroenendaalF, Wezel-MeijlerGv. Neonatal care bundles are associated with a reduction in the incidence of intraventricular haemorrhage in preterm infants: A multicentre cohort study. Arch Dis Child Fetal Neonatal Ed. 2020;105(4):419–24.
70.
BrionLP, BellEF, RaghuveerTS. Vitamin E supplementation for prevention of morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2003(4):CD003665.
71.
FowliePW, DavisPG, McGuireW. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev. 2010(7):CD000174.
KuncelNR, OnesDS, SackettPR. Individual differences as predictors of work, educational, and broad life outcomes. Pers Individ Differ. 2010;49(4):331–6.
